Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis

BACKGROUND: Atrial fibrillation is the most common arrhythmia of the heart with a prevalence of approximately 2% in the western world. Atrial flutter, another arrhythmia, occurs less often with an incidence of approximately 200,000 new patients per year in the USA. Patients with atrial fibrillation...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Naqash J., Safi, Sanam, Feinberg, Joshua, Nielsen, Emil E., Gluud, Christian, Jakobsen, Janus C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382469/
https://www.ncbi.nlm.nih.gov/pubmed/28381269
http://dx.doi.org/10.1186/s13643-017-0470-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382469/
https://www.ncbi.nlm.nih.gov/pubmed/28381269
http://dx.doi.org/10.1186/s13643-017-0470-2

Ejemplares similares